LSP Life Sciences Fund Monthly Report August 2013 € NAV per Share

First Page		Document Content
Date: 2014-03-03 04:46:57 Investment Financial services Funds Collective investment schemes Financial economics MorphoSys Genmab		LSP Life Sciences Fund Monthly Report August 2013 € NAV per Share Add to Reading List Source URL: www.lspvc.com Download Document from Source Website File Size: 167,00 KB Share Document on Facebook

	LSP Life Sciences Fund Monthly Report August 2013 € NAV per Share DocID: 1gegX - View Document
	Media Release Martinsried/Munich, Germany, and Groningen, The Netherlands, May 7, 2015 MorphoSys Acquires Peptide Therapeutic Company Lanthio Pharma Acquisition Adds Novel Candidates Including Pre-IND Candidate for Fibro DocID: 1gdCh - View Document
	Media Release Martinsried/Munich and Darmstadt, Germany, 12 June 2014 MorphoSys and Merck Serono Enter Strategic Immuno-Oncology Collaboration  DocID: 1emv7 - View Document
	Medienmitteilung Martinsried/München, 21. Mai 2015 MorphoSys präsentiert Daten zu firmeneigenen Programmen auf dem 20ten Kongress der European Hematology Association Aussagekräftige Datenpakete zu den am weitesten for DocID: 1ei8d - View Document
	Media Release Martinsried/Munich, Germany, January 10, 2013 MorphoSys Completes Sale of AbD Serotec to Bio-Rad MorphoSys AG (FSE: MOR; Prime Standard Segment, TecDAX) announced today that the sale of its research and dia DocID: RV7k - View Document